MedPath

Efficacy of Rasonadi Churna on Hyperandrogenism in PCOS affecting menstrual irregularities.

Phase 2
Registration Number
CTRI/2024/05/067094
Lead Sponsor
Dr Rekha Chhagan Kuwar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Married and Unmarried patients of PCOS with Rotterdam criteria.

Exclusion Criteria

Patients having

- Hypogonadotrophic hypogonadism.

- Premature ovarian failure.

- Congenital adrenal hyperplasia.

- Hyperprolactenemia.

- Thyroid abnormalities.

- Tuberculosis.

- Congenital anomalies.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath